N-Cadherin Monoclonal Antibody
Conditions of optimal N-cadherin monoclonal antibody performance should be determined experimentally by the investigator.
Conditions of optimal N-cadherin monoclonal antibody performance should be determined experimentally by the investigator.
Conditions of optimal Smad4 DPC4 monoclonal antibody performance should be determined experimentally by the investigator.
Conditions of optimal tropomyosin (sarcomeric) monoclonal antibody performance should be determined experimentally by the investigator.
Conditions of optimal vimentin monoclonal antibody performance should be determined experimentally by the investigator.
Nano Separation TruPurity™ FPLC System (catalog No. STP 030) is designed for laboratory-level process research and method development, catering to the purification of target products such as proteins, antibodies, vaccines, nucleic acids, and diagnostic materials ranging...
Conditions of optimal IL-2 monoclonal antibody performance should be determined experimentally by the investigator.
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
In vivo grade recombinant human IgG3 kappa isotype control. Low or no specific binding to human samples tested. Humanized variable regions, and human IgG3 kappa constant regions. The lowest prices for bulk order.
Recombinant anti-HEL VHH isotype control antibodies (nanobody, single-domain antibody, or the variable domain of heavy chain antibody) good for in vitro and in vivo studies. Low or no specific binding to human, mouse, and rat...
Recombinant anti-HEL VHH isotype control antibodies (nanobody, single-domain antibody, or the variable domain of heavy chain antibody) good for in vitro and in vivo studies. Low or no specific binding to human, mouse, and rat...